EPS for Fortress Biotech (FBIO) Expected At $-0.33; Marin Software Has 0.67 Sentiment

Analysts expect Fortress Biotech Inc (NASDAQ:FBIO) to report $-0.33 EPS on May, 9.They anticipate $0.02 EPS change or 6.45% from last quarter’s $-0.31 EPS. After having $-0.43 EPS previously, Fortress Biotech Inc’s analysts see -23.26% EPS growth. It closed at $3.71 lastly. It is down 24.50% since September 27, 2016 and is uptrending. It has outperformed by 13.93% the S&P500.

Marin Software Incorporated provides a cross-channel, cross-device, enterprise marketing software platform for search, display and social advertising channels. The company has market cap of $70.94 million. The Company’s enterprise marketing software platform is offered as an integrated software-as-a-service solution for advertisers and agencies. It currently has negative earnings. The Company’s platform enables digital marketers to manage performance of their online advertising campaigns.

It closed at $1.75 lastly. It is down 26.78% since September 27, 2016 and is downtrending. It has underperformed by 37.34% the S&P500.

Ratings analysis reveals 67% of Marin Software’s analysts are positive. Out of 3 Wall Street analysts rating Marin Software, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $5 while the high is $10. The stock’s average target of $6.67 is 281.14% above today’s ($1.75) share price. MRIN was included in 6 notes of analysts from August 6, 2015. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, May 6. The firm earned “Buy” rating on Monday, February 22 by UBS. The rating was downgraded by Stifel Nicolaus on Thursday, August 25 to “Hold”. The firm earned “Buy” rating on Thursday, August 6 by Stifel Nicolaus. The stock of Marin Software Inc (NYSE:MRIN) has “Buy” rating given on Thursday, August 6 by UBS. The stock of Marin Software Inc (NYSE:MRIN) has “Buy” rating given on Thursday, August 6 by Deutsche Bank.

Raging Capital Management Llc holds 0.56% of its portfolio in Marin Software Inc for 3.22 million shares. Crosslink Capital Inc owns 738,027 shares or 0.28% of their US portfolio. Moreover, Penn Capital Management Co Inc has 0.18% invested in the company for 1.20 million shares. The California-based Stonebridge Capital Management Inc has invested 0.05% in the stock. Temasek Holdings (Private) Ltd, a Singapore-based fund reported 2.53 million shares.